Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAT | P00750 | 3/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.35 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 4/20 | 0.35 |
| ▸ | HCRTR2 | O43614 | 4/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27770364 | 0.80 | RXFP1 (0.39) | PLAT | |
| SCHEMBL27749306 | 0.78 | PTPN11 (0.37) | HSD11B1CNR2 | |
| SCHEMBL28079903 | 0.74 | HTR2A (0.39) | PLAT | |
| SCHEMBL27770358 | 0.67 | PDE4A (0.32) | NPSR1 | |
| SCHEMBL27837877 | 0.67 | — | — | |
| SCHEMBL27770354 | 0.66 | GAA (0.39) | NPSR1 | |
| SCHEMBL387689 | 0.65 | RXFP1 (0.45) | PLATS1PR1POLBNPSR1TRPA1 | |
| SCHEMBL27640356 | 0.64 | HCAR1 (0.41) | POLBNPSR1TRPA1SCN9AHCAR1 | |
| SCHEMBL7701143 | 0.63 | ALDH1A1 (0.50) | S1PR1POLBNPSR1TRPA1SCN9A | |
| SCHEMBL28058456 | 0.62 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102369190-A | Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency | BAYER SCHERING PHARMA AG | 2012-03-07 | — | — | CN | disclosed |